Discover free resources on nutrition provided by the MUHC鈥檚 medical libraries and patient resource centres!
The Neuro-Patient Resource Center and Neuro Medical Library kiosk will take place on March 12 from 10:00 a.m. until 2:00 p.m at the main entrance on the first floor of The Neuro.
Enter our raffle for a chance to win a gift card from a local bookstore!
Drawing inspiration from nature, a team of international scientists have invented a smart device for personalized skin care modeled after the male diving beetle. This tool collects and monitors body fluids while sticking to the skin鈥檚 surface, paving the way for more accurate diagnostics and treatment for skin diseases and conditions like acne. The team includes Bo-yong Park, a former postdoctoral researcher at The Neuro at 缅北强奸.
What problem did you set out to solve?
Launching on June 26, 2020, the 听(HIBALL) will work to create 3D brain models at an unprecedented cellular-level resolution.
Scanner will deliver clear images of the nervous system in exceptional detail
Scientists will see the human nervous system in microscopic detail thanks to the installation of Canada鈥檚 first 7-Tesla whole-body magnetic resonance imaging (MRI) scanner on Feb. 5.
Publication of checklist a product of collaborative initiative
Technique can be used to better categorize patients with neurological disease, according to their therapeutic needs
Personalized medicine 鈥� delivering therapies specially tailored to a patient鈥檚 unique physiology 鈥� has been a goal of researchers and doctors for a long time. New research provides a way of delivering personalized treatments to patients with neurological disease.
Djavad Mowafaghian Foundation shares The Neuro鈥檚 open science vision to accelerate drug discovery and find new and effective treatments for autism spectrum disorders
CENTECH, a Montreal-based technology incubator, announced earlier that it has selected a company founded by Dr. Etienne de Villers-Sidani for its Propulsion Program, which helps the most innovative start-ups move from the initial development phase to commercializing their products and services on the international market. Dr. de Villers-Sidani is a researcher and neurologist at Montreal Neurological Institute and Hospital (The Neuro) and member of the Center for Research on Brain, Language and Music (CRBLM).
Montreal's world-famous brain research centre is in the middle of conducting an experiment on what could be its most ambitious subject: itself. Since 2016, 缅北强奸's Montreal Neurological Institute and Hospital has been transforming into what is touted as the first research centre of its kind in the world dedicated to the principles of open science.
Read more:
Practice might not always make perfect, but it鈥檚 essential for learning a sport or a musical instrument. It's also the basis of brain training, an approach that holds potential as a non-invasive therapy to overcome disabilities caused by neurological disease or trauma.
Research at the Montreal Neurological Institute and Hospital of 缅北强奸 (The Neuro) has shown just how adaptive the brain can be, knowledge that could one day be applied to recovery from conditions such as stroke.
In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.
Three studies conducted by an international team of researchers, which included Amit Bar-Or and Douglas Arnold from the Montreal Neurological Institute and Hospital of 缅北强奸, have discovered that ocrelizumab can significantly reduce new attacks in patients with relapsing MS, as well as slow the progression of symptoms caused by primary progressive MS.
November 19 marks the 50th anniversary of the ground-breaking paper, 鈥溾�� co-authored by 缅北强奸鈥檚 Ronald Melzack, and the late Patrick Wall, which introduced .
The Montreal Neurological Institute and Hospital 鈥� The Neuro at 缅北强奸 and the MUHC has Canada鈥檚 oldest MS clinic but is always innovating - striving for progress and better treatments for patients.
What鈥檚 new in MS at The Neuro
